GLP-1 Secretion Is Increased upon Blockade of the Somatostatin Receptor Subtype 2 and 5 Resulting in GLP-1 Receptor-Mediated Lowering of Blood Glucose in Mice

被引：1
|
作者：
Jepsen, Sara L.
Albrechtsen, Nicolai J. Wewer
Pedersen, Jens
Engelstoft, Maja S.
Deacon, Carolyn F.
Holst, Jens J.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1968-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Regulation of Endogenous Rodent GLP-1 and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5
    Farb, Thomas B.
    Adeva, Marta
    Beauchamp, Thomas J.
    Cabrera, Over
    Coates, David A.
    Deshea Meredith, Tamika
    Droz, Brian A.
    Efanov, Alexander
    Ficorilli, James V.
    Gackenheimer, Susan L.
    Martinez-Grau, Maria A.
    Molero, Victoriano
    Ruano, Gema
    Statnick, Michael A.
    Suter, Todd M.
    Syed, Samreen K.
    Toledo, Miguel A.
    Willard, Francis S.
    Zhou, Xin
    Bokvist, Krister B.
    Barrett, David G.
    DIABETES, 2017, 66 : A25 - A26
  • [22] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [23] The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
    Alvarez, E
    Martínez, MD
    Roncero, I
    Chowen, JA
    García-Cuartero, B
    Gispert, JD
    Sanz, C
    Vázquez, P
    Maldonado, A
    de Cáceres, J
    Desco, M
    Pozo, MA
    Blázquez, E
    JOURNAL OF NEUROCHEMISTRY, 2005, 92 (04) : 798 - 806
  • [24] Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5
    Farb, Thomas B.
    Adeva, Marta
    Beauchamp, Thomas J.
    Cabrera, Over
    Coates, David A.
    Meredith, Tamika DeShea
    Droz, Brian A.
    Efanov, Alexander
    Ficorilli, James V.
    Gackenheimer, Susan L.
    Martinez-Grau, Maria A.
    Molero, Victoriano
    Ruano, Gema
    Statnick, Michael A.
    Suter, Todd M.
    Syed, Samreen K.
    Toledo, Miguel A.
    Willard, Francis S.
    Zhou, Xin
    Bokvist, Krister B.
    Barrett, David G.
    ENDOCRINOLOGY, 2017, 158 (11) : 3859 - 3873
  • [25] Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
    Aulinger, Benedikt A.
    Bedorf, Anne
    Kutscherauer, Gabriele
    de Heer, Jocelyn
    Holst, Jens J.
    Goeke, Burkhard
    Schirra, Joerg
    DIABETES, 2014, 63 (03) : 1079 - 1092
  • [26] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [27] The role of GLP-1 in type 2 diabetes (T2D): effects of DPP-4 inhibition and GLP-1 receptor blockade
    Aulinger, B. A.
    de Heer, J.
    Bedorf, A.
    Kutscherauer, G.
    Goeke, B.
    Schirra, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [28] A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice
    Hornigold, David C.
    Roth, Emma
    Howard, Victor
    Will, Sarah
    Oldham, Stephanie
    Coghlan, Matthew P.
    Blouet, Clemence
    Trevaskis, James L.
    APPETITE, 2018, 127 : 334 - 340
  • [29] Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice
    Lamont, Benjamin J.
    Li, Yazhou
    Kwan, Edwin
    Brown, Theodore J.
    Gaisano, Herbert
    Drucker, Daniel J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (01): : 388 - 402
  • [30] Increased pancreatic islet GLP-1 content and release in mice with deletion of glucagon receptor
    Li, X.
    Ge, L.
    Xu, S.
    Jiang, G.
    Mu, J.
    Liu, F.
    Wang, L.
    Fischer, P.
    Charron, M. J.
    Zhou, Y. -P.
    Howard, A. D.
    Zhang, B. B.
    DIABETOLOGIA, 2009, 52 : S164 - S164
12345